Niva Bupa Health Insurance Company Ltd
₹ 73.3
-0.89%
21 Nov
4:00 p.m.
About
Incorporated in 2008, Niva Bupa Health Insurance Ltd is Tech driven leading health insurer in India.[1]
[
edit about
]
[
add key points
]
- Market Cap ₹ 13,390 Cr.
- Current Price ₹ 73.3
- High / Low ₹ 81.0 / 69.2
- Stock P/E 164
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 4.85 %
- ROE 5.69 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of -3.86% over last 3 years.
- Earnings include an other income of Rs.221 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Upcoming result date: 25 November 2024
Profit & Loss
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
1,057 | 1,413 | 2,149 | 2,853 | 4,115 | |
1,094 | 1,435 | 2,326 | 3,183 | 4,225 | |
Operating Profit | -37 | -22 | -177 | -330 | -110 |
OPM % | -3% | -2% | -8% | -12% | -3% |
0 | 0 | 7 | 374 | 221 | |
Interest | 4 | 6 | 0 | 0 | 0 |
Depreciation | 21 | 22 | 27 | 32 | 29 |
Profit before tax | -62 | -50 | -197 | 13 | 82 |
Tax % | 0% | 0% | 0% | 0% | 0% |
-62 | -50 | -197 | 13 | 82 | |
EPS in Rs | |||||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 43% |
TTM: | 44% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 54% |
TTM: | 553% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -4% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 |
Reserves | -780 | -773 | -903 | -683 | 351 |
0 | 0 | 250 | 250 | 250 | |
891 | 1,322 | 1,983 | 2,799 | 3,891 | |
Total Liabilities | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 |
39 | 46 | 49 | 52 | 58 | |
CWIP | 2 | 2 | 1 | 4 | 1 |
Investments | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 |
129 | 230 | 287 | 455 | 675 | |
Total Assets | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
257 | 338 | 593 | 813 | ||
-374 | -723 | -829 | -1,882 | ||
280 | 374 | 280 | 1,110 | ||
Net Cash Flow | 164 | -12 | 43 | 41 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 0 | 0 | 0 | 0 | 0 |
Inventory Days | |||||
Days Payable | |||||
Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 |
Working Capital Days | -270 | -290 | -298 | -313 | -298 |
ROCE % | -10% | -30% | 1% | 5% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17h - Earnings call scheduled for November 25, 2024.
-
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Financial Results
17h - Board meeting scheduled for financial results approval.
-
Disclosure Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015
14 Nov - Disclosure of authorized personnel for materiality assessment.
-
Closure of Trading Window
14 Nov - Closure of trading window for designated persons.
-
Intimation Pursuant To Regulation 8(1) And 8(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015
14 Nov - Adoption of Code for Fair Disclosure of UPSI.